Merit Medical Systems, Inc. (MMSI)
MMSI's Stock Declines Despite Q3 Earnings Beat, Higher Gross Margin
Merit Medical benefits from revenue growth in both segments and all its product categories within its Cardiovascular unit in the third quarter.
Merit Medical Systems, Inc. (MMSI) Q3 2024 Earnings Call Transcript
Merit Medical Systems, Inc. (NASDAQ:MMSI ) Q3 2024 Earnings Conference Call October 30, 2024 5:00 PM ET Company Participants Fred Lampropoulos - Founder, Chairman & Chief Executive Officer Brian Lloyd - Chief Legal Officer & Corporate Secretary Joe Wright - President Raul Parra - Chief Financial Officer Conference Call Participants John Young - Canaccord Jayson Bedford - Raymond James Jason Bednar - Piper Sandler David Rescott - R.W. Baird Mike Matson - Needham Craig Bijou - Bank of America Securities Jim Sidoti - Sidoti & Company Michael Petusky - Barrington Research Steve Lichtman - Oppenheimer Operator Good day, and thank you for standing by.
Compared to Estimates, Merit Medical (MMSI) Q3 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for Merit Medical (MMSI) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Merit Medical (MMSI) Q3 Earnings and Revenues Surpass Estimates
Merit Medical (MMSI) came out with quarterly earnings of $0.86 per share, beating the Zacks Consensus Estimate of $0.80 per share. This compares to earnings of $0.75 per share a year ago.
Why Merit Medical (MMSI) is Poised to Beat Earnings Estimates Again
Merit Medical (MMSI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Merit Medical Stock Gains 24.7% Year to Date: What's Behind the Rally?
MMSI shows strong growth momentum with a robust product portfolio and recent acquisitions, positioning itself well in competitive healthcare markets.
Here's Why You Should Retain Merit Medical Stock in Your Portfolio
Merit Medical's (MMSI) strong product portfolio raises optimism about the stock.
MMSI Stock Likely to Gain From Cook Medical's Product Portfolio Buyout
Merit Medical expects to solidify its foothold in the underpenetrated global lead management market via the latest asset acquisition.
Merit Medical Stock Falls Despite Positive WRAPSODY Trial Results
MMSI announces 6-month results from its WRAPSODY WAVE trial, showing superior efficacy in extending AV fistula patency for dialysis patients.
Merit Medical Gains 26.4% Year to Date: What's Driving the Stock?
MMSI's shares gain on the back of strength in its Cardiovascular segment and a robust product portfolio.
Merit Medical Systems, Inc. (MMSI) Q2 2024 Earnings Call Transcript
Merit Medical Systems, Inc. (NASDAQ:MMSI ) Q2 2024 Results Conference Call August 1, 2024 5:00 PM ET Company Participants Fred Lampropoulos - Founder, Chairman, and Chief Executive Officer Brian Lloyd - Chief Legal Officer and Corporate Secretary Joe Wright - President Raul Parra - Chief Financial Officer Conference Call Participants Jason Bednar - Piper Sandler Mike Matson - Needham Larry Biegelsen - Wells Fargo Steve Lichtman - Oppenheimer David Rescott - Baird Jayson Bedford - Raymond James Craig Bijou - Bank of America Securities John Young - Canaccord Jim Sidoti - Sidoti & Company Operator Ladies and gentlemen, thank you for standing by. Welcome to the Merit Medical Systems Second Quarter 2024 Earnings Conference Call.
Merit Medical (MMSI) Q2 Earnings & Revenues Beat, '24 View Up
Merit Medical's (MMSI) second-quarter results reflect growth in earnings and revenues. Operating margin expands.
